Evidence map›Paper›PMID 40630394›Full record

ArticleFrontiers in physiology2025

Alterations in CNS-derived blood biomarkers during 30 days simulated microgravity.

Susanne V Schmidt, Alexandru Odainic, Benjamin Aretz, Petra Frings-Meuthen, Jan-Niklas Hoenemann, Maria Bohmeier, Christian Liemersdorf, Edwin Mulder, Stefan Moestl, Karsten Heusser and 3 more

Abstract read
In one paragraph

Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Susanne V SchmidtInstitute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
Alexandru OdainicInstitute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany.
Benjamin AretzInstitute for Medical Biometry, Informatics and Epidemiology (IMBIE), University of Bonn, Bonn, Germany.
Petra Frings-MeuthenInstitute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.
Jan-Niklas HoenemannInstitute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.
Maria BohmeierInstitute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.
Christian LiemersdorfInstitute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.
Edwin MulderInstitute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.
Stefan MoestlInstitute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.
Karsten HeusserInstitute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.
Jens TankInstitute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.
Jens JordanInstitute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.
Laura de BoniInstitute of Aerospace Medicine, German Aerospace Center (DLR), Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Spaceflight induces physiological adaptations, including headward fluid shifts that may impact the central nervous system (CNS). Ground-based analogs such as 6° head-down tilt bed rest (HDTBR) provide a controlled setting to study these neurophysiological effects and assess CNS biomarkers. We therefore analyzed neurological function and CNS-derived blood biomarkers during four NASA-backed 30-day strict HDTBR campaigns to better understand neurophysiological responses to prolonged fluid redistribution. Methods: Forty participants (18 women, 22 men; mean age ∼36 years) were assigned to different countermeasure groups: lower body negative pressure (LBNP), cycling in HDT followed by wearing thigh cuffs, upright sitting (positive control), and HDTBR without countermeasures. Neurological exams and blood biomarker analyses (SIMOA Quanterix) were performed to assess NfL, GFAP, Aβ Results: No clinical neurological impairments were observed. The LBNP group exhibited robust increases in amyloid-related biomarkers during HDTBR, which persisted into the recovery period. Analysis of within-subject changes over time revealed additional effects. In the cycling and cuffs group, NFL levels increased progressively throughout the study. In the control group, GFAP levels rose gradually, indicating mild glial activation. Tau protein also increased in the LBNP group but returned to baseline levels during the recovery phase. Discussion: These findings highlight subtle but biologically relevant CNS-related changes in response to different countermeasure strategies during 30-day strict HDTBR. LBNP may enhance metabolite clearance, as reflected in increased Aβ washout. These findings support the use of LBNP as a potential countermeasure to protect brain health during spaceflight and analog missions.

Indexed as

biomarkerCNSgliahead down tilt bed restneurons

Identifiers

PMID40630394
PMCPMC12234515

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.